Next Article in Journal
Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer
Previous Article in Journal
Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes
 
 
Review

Article Versions Notes

Cancers 2024, 16(17), 3069; https://doi.org/10.3390/cancers16173069
Action Date Notes Link
article xml file uploaded 3 September 2024 16:36 CEST Original file -
article xml uploaded. 3 September 2024 16:36 CEST Update -
article pdf uploaded. 3 September 2024 16:36 CEST Version of Record https://www.mdpi.com/2072-6694/16/17/3069/pdf-vor
article html file updated 3 September 2024 16:38 CEST Original file -
article xml file uploaded 3 September 2024 17:02 CEST Update -
article xml uploaded. 3 September 2024 17:02 CEST Update -
article pdf uploaded. 3 September 2024 17:02 CEST Updated version of record https://www.mdpi.com/2072-6694/16/17/3069/pdf-vor
article html file updated 3 September 2024 17:03 CEST Update -
article xml file uploaded 11 September 2024 05:23 CEST Update -
article xml uploaded. 11 September 2024 05:23 CEST Update -
article pdf uploaded. 11 September 2024 05:23 CEST Updated version of record https://www.mdpi.com/2072-6694/16/17/3069/pdf-vor
article html file updated 11 September 2024 05:26 CEST Update -
article xml file uploaded 11 September 2024 06:24 CEST Update -
article xml uploaded. 11 September 2024 06:24 CEST Update https://www.mdpi.com/2072-6694/16/17/3069/xml
article pdf uploaded. 11 September 2024 06:24 CEST Updated version of record https://www.mdpi.com/2072-6694/16/17/3069/pdf
article html file updated 11 September 2024 06:26 CEST Update https://www.mdpi.com/2072-6694/16/17/3069/html
Back to TopTop